Trials in Long Beach, California
Here are the top 10 medical studies for prostate cancer in Long Beach, California
Popular Filters
Phase 3 Trials
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Hormone Therapy
AZD5305 for Prostate Cancer
Recruiting1 awardPhase 3
Fountain Valley, California
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Taxane
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Cerritos, California
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Trials With No Placebo
Behavioral Intervention
Exercise Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial is studying how regular walking exercises at home affect people with low-risk prostate cancer who are being monitored but not actively treated. Participants will either follow a specific walking routine or continue their usual exercise habits. Researchers aim to see if the walking routine has any impact on prostate cancer indicators.
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Monoclonal Antibodies
REGN5678 +/- Cemiplimab for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Santa Monica, California
This trial is testing a new drug, REGN5678, to see if it is safe and effective in treating prostate cancer. The study will also look at how well the drug is tolerated and how it works in the body.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.